Essentra, a leading global provider of specialist packaging and authentication solutions, has expanded its footprint and capabilities with the recent acquisition of the pharmaceutical assets of Kamsri Printing & Packaging Pvt. Ltd. in India.
Headquartered in the UK and listed on the FTSE 250, Essentra has c. 9,000 employees across 33 countries. The company, which has been present in India for 16 years, currently employs 170 people in Bangalore and through this acquisition will create an additional 120 local jobs. Essentra also has a successful joint venture with ITC in Filter Products, which includes a further two manufacturing facilities and 150 employees.
PT Sreekumar, Managing Director – Asia for Essentra, said: “With its highly complementary product range, Kamsri provides us with an entry point into the attractive pharmaceutical and healthcare industries in India, thereby reinforcing our global packaging capabilities and enhancing the opportunities for our customers.
Our Health & Personal Care Packaging business now has a manufacturing presence in North America, Europe and India, and ships our extensive range of innovative products to 75 countries worldwide.”
The acquired cartons manufacturing assets which will incorporated into Essentra’s existing site which opened in late 2013, and accommodates manufacturing, warehousing and commercial infrastructure over 70,000 sq. ft.
General Manager – Essentra India, Narayan, said: “Continued growth in the local market, and its increasing status as a high quality, competitive manufacturing base, make India a key opportunity for the Essentra Group. The end-markets for our specialist components, such as healthcare and industrial products, are sizeable and well-established, with annual growth of up to 20%.
Following the acquisition of Kamsri, our immediate focus will be adding their cartons capabilities to our existing tear tapes and securing solutions for packaging; however, we plan to further extend our specialist packaging range over the coming year.”
